ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Molsidomine (MOL) reducespostoperative pelvic adhesion: A rat uterine horn model

Isil Koleli, Hakan Parlakpinar, Onural Ozhan, Kevser Tanbek, Nurhan Sahin, Ercan Yilmaz, Bahar Sariibrahim, Lale Bakir.



Abstract
 Download PDF Cited by 0 ArticlesPost

Aim: Postoperative pelvic adhesions (PPAs) are a common complication that leads to many problems. This study aimed to compare the role of Seprafilm (a protective barrier), and molsidomine (MOL), recognized for its antioxidative and antiproliferative effects, in preventing pelvic adhesion.
Material and Methods: A total of 30 of female Wistar albino rats were randomly divided into 3 groups. They underwent bilateral uterine horn injury. The rats in the Sham group (n=10) received no special treatment. The rats in the Seprafilm group (n=10) were treated withSeprafilm. The rats in the MOL group (n=10) received 10 mg/kg MOL orally for 14 days. Adhesion scores were evaluated using macroscopic, microscopic, and immunohistochemical grading 14 days postoperatively.
Results:The Majuzi adhesion score of the rats in the MOL group [1 (0-4)] was lower than the score of the rats in the sham [4 (2-5)] and Seprafilm [4 (1-5)] (p

Key words: Seprafilm; Hyaluronic Acid; Molsidomine; Pelvic Adhesions.

Bibliomed Article Statistics

30
24
23
31
20
18
37
34
22
40
17
6
R
E
A
D
S

30

14

11

13

8

25

23

25

20

16

13


D
O
W
N
L
O
A
D
S
070809101112010203040506
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com


ejPort - eJManager.com
Author Tools
 About BiblioMed
License Information
Terms & Conditions
Privacy Policy
 Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.